| Mir-34: a new weapon against cancer? G Misso, MT Di Martino, G De Rosa, AA Farooqi, A Lombardi, V Campani, ... Molecular therapy-nucleic acids 3, 2014 | 549 | 2014 |
| BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells P Tassone, P Tagliaferri, A Perricelli, S Blotta, B Quaresima, ML Martelli, ... British journal of cancer 88 (8), 1285-1291, 2003 | 442 | 2003 |
| MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches N Amodio, L Raimondi, G Juli, MA Stamato, D Caracciolo, P Tagliaferri, ... Journal of hematology & oncology 11, 1-19, 2018 | 248 | 2018 |
| Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence MT Di Martino, E Leone, N Amodio, U Foresta, M Lionetti, MR Pitari, ... Clinical cancer research 18 (22), 6260-6270, 2012 | 248 | 2012 |
| Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy P Correale, MS Rotundo, MT Del Vecchio, C Remondo, C Migali, ... Journal of immunotherapy (Hagerstown, Md.: 1997) 33 (4), 435, 2010 | 238 | 2010 |
| Familial papillary thyroid microcarcinoma: a new clinical entity G Lupoli, G Vitale, M Caraglia, MR Fittipaldi, A Abbruzzese, P Tagliaferri, ... The Lancet 353 (9153), 637-639, 1999 | 229 | 1999 |
| Targeting miR-21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth E Leone, E Morelli, MT Di Martino, N Amodio, U Foresta, A Gullà, M Rossi, ... Clinical Cancer Research 19 (8), 2096-2106, 2013 | 209 | 2013 |
| Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro P Tassone, P Tagliaferri, C Viscomi, C Palmieri, M Caraglia, ... British journal of cancer 88 (12), 1971-1978, 2003 | 200 | 2003 |
| Growth inhibition and synergistic induction of apoptosis by zoledronate and dexamethasone in human myeloma cell lines P Tassone, S Forciniti, E Galea, G Morrone, MC Turco, V Martinelli, ... Leukemia 14 (5), 841-844, 2000 | 194 | 2000 |
| miR‐29b negatively regulates human osteoclastic cell differentiation and function: Implications for the treatment of multiple myeloma‐related bone disease M Rossi, MR Pitari, N Amodio, MT Di Martino, F Conforti, E Leone, C Botta, ... Journal of cellular physiology 228 (7), 1506-1515, 2013 | 193 | 2013 |
| A prospective randomized comparison between laparoscopic and laparotomic approaches in women with early stage endometrial cancer: a focus on the quality of life F Zullo, S Palomba, T Russo, A Falbo, M Costantino, A Tolino, E Zupi, ... American journal of obstetrics and gynecology 193 (4), 1344-1352, 2005 | 191 | 2005 |
| Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity N Amodio, MA Stamato, G Juli, E Morelli, M Fulciniti, M Manzoni, E Taiana, ... Leukemia 32 (9), 1948-1957, 2018 | 185 | 2018 |
| miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1 N Amodio, MT Di Martino, U Foresta, E Leone, M Lionetti, M Leotta, ... Cell death & disease 3 (11), e436-e436, 2012 | 177 | 2012 |
| Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: a meta-analysis of randomised trials D Ciliberto, C Botta, P Correale, M Rossi, M Caraglia, P Tassone, ... European journal of cancer 49 (3), 593-603, 2013 | 163 | 2013 |
| DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma N Amodio, M Leotta, D Bellizzi, MT Di Martino, P D'Aquila, M Lionetti, ... Oncotarget 3 (10), 1246, 2012 | 161 | 2012 |
| Laparoscopic surgery vs laparotomy for early stage endometrial cancer: long-term data of a randomized controlled trial F Zullo, S Palomba, A Falbo, T Russo, R Mocciaro, E Tartaglia, ... American journal of obstetrics and gynecology 200 (3), 296. e1-296. e9, 2009 | 157 | 2009 |
| In vitro and in vivo anti-tumor activity of miR-221/222 inhibitors in multiple myeloma MT Di Martino, A Gullà, MEG Cantafio, M Lionetti, E Leone, N Amodio, ... Oncotarget 4 (2), 242, 2013 | 155 | 2013 |
| Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma S Blotta, J Jakubikova, T Calimeri, AM Roccaro, N Amodio, AK Azab, ... Blood, The Journal of the American Society of Hematology 120 (25), 5002-5013, 2012 | 140 | 2012 |
| Current approaches and perspectives in the therapy of medullary thyroid carcinoma G Vitale, M Caraglia, A Ciccarelli, G Lupoli, A Abbruzzese, P Tagliaferri, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2001 | 137 | 2001 |
| Desferioxamine increases iron depletion and apoptosis induced by ara‐C of human myeloid leukaemic cells A Leardi, M Caraglia, C Selleri, S Pepe, C Pizzi, R Notaro, A Fabbrocini, ... British journal of haematology 102 (3), 746-752, 1998 | 135 | 1998 |
Pierfrancesco TassoneProfessor of Medical Oncology, Magna Graecia University, Catanzaro, Italy在 unicz.it 的电子邮件经过验证
